The Case for Direct Measurement of Urinary Ammonium: An Interview
In a recent Perspective published in AJKD, Jaime Uribarri and colleagues review the literature on urinary ammonium excretion (UNH4) in an attempt to establish reference [...]
CKD progression
Can We Predict the Risk of CKD Progression Based on Routinely Available Laboratory Tests?
Chronic kidney disease (CKD) is a significant public health issue that affects more than 37 million individuals in the United States. Due to its progressive nature and the [...]
Highlights From the February 2022 Issue
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic [...]
Is New Always Better? Apixaban vs. Warfarin and CKD Progression
Atrial fibrillation (AF) is the most common arrhythmia in patients with chronic kidney disease (CKD), with a prevalence of nearly 24.5%. This is over 2 times higher than [...]
Association of Blood Pressure With the Progression of CKD: Are We Any Further Forward?
Lowering blood pressure (BP) is beneficial in patients with chronic kidney disease (CKD) from a cardiovascular protection point of view, and has formed the basis of our [...]
“Doc, I heard on the news that this heartburn medicine is bad for my kidneys. What should I do?”
Proton pump inhibitors (PPIs) are amongst the most frequently prescribed medications with an estimated 15 million in the US taking prescription PPIs, making the estimated [...]
Can Sevelamer Reduce Proteinuria in Patients With CKD? Do We Have An ANSWER?
In the United States, approximately 37 million people in the United States have chronic kidney disease (CKD), and in 2016, there were more than 720,000 patients with ESRD on [...]